United States · FDA National Drug Code directory
Tivicay PD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49702-255_edfff6ba-b810-49ff-a578-f03b9544e886
- Product NDC
- 49702-255
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- dolutegravir sodium
- Labeler
- ViiV Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200612
- Source listing expiry
- 20271231
Source-listed ingredients
- DOLUTEGRAVIR SODIUM — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE · 49702-255-37
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →